Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mrunalini K. Gaydhane"'
Publikováno v:
RSC Advances. 13:7312-7328
Various approaches to control the release of active molecules or drug molecules through electrospun polymeric nanofibers.
Publikováno v:
Journal of Materials Research. 35:600-609
Bioactive dressings which can treat any kind of chronic or acute wounds and can fully replace the conventional gauzes and superabsorbent dressings have proven to be a future market of wound care products in recent times. These dressings are multifunc
Publikováno v:
Nanotechnology in Textiles ISBN: 9781003055815
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c775fc4059c8712a46d38015a6e0b58
https://doi.org/10.1201/9781003055815-17
https://doi.org/10.1201/9781003055815-17
Autor:
Shivakalyani Adepu, Manohar Kakunuri, Stephen J. Eichhorn, Chandra Shekhar Sharma, Mudrika Khandelwal, Mrunalini K. Gaydhane
Publikováno v:
Applied Surface Science. 426:755-762
Sustained release and prevention of burst release for low half-life drugs like Diclofenac sodium is crucial to prevent drug related toxicity. Electrospun nanofibers have emerged recently as potential carrier materials for controlled and sustained dru
Publikováno v:
Journal of Applied Polymer Science. 138:50003
Publikováno v:
Materials Today Communications. 24:100953
Oral administration of Amphotericin B (AmB) is abstained due to its poor bioavailability and high toxicity. Current intravenous lipid formulations are delivered as 3−5 mg AmB/kg of body weight, due to its dose dependent nephrotoxicity. In this work
Autor:
Urbashi Mahanta, Chandra Shekhar Sharma, Seeram Ramakrishna, Mrunalini K. Gaydhane, Mudrika Khandelwal
Publikováno v:
Biomanufacturing Reviews. 3
Cultured meat or in vitro meat offers a safe and disease-free way forward to meet increasing meat requirement without involving animal sacrifices and at the same time, reducing greenhouse emissions, as compared to conventional meat. However, its cost
Publikováno v:
Nano-Structures & Nano-Objects. 19:100367
Amphotericin B (AmB) is one of the potent antimycotic drugs used to cure invasive fungal infections and Leishmaniasis. However, it’s appalling collateral toxicity restricts its applicability for only parenteral administration with frequent dosing.